AR-ENCAP DIN 02239529
Health Canada record
| Active ingredient(s) | BOSWELLIA SERRATA 100 MG; HARPAGOPHYTUM PROCUMBENS 200 MG; XANTHOXYLUM 250 MG |
|---|---|
| Dosage form | Capsule |
| Route | Oral |
| Schedule | |
| Class | Human |
| ATC | |
| Original market date | |
| Current status date | 23-Mar-2018 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
International API supply for BOSWELLIA SERRATA
1 active FDA Drug Master Files.
Request a quote for AR-ENCAP